The immunological barrier to xenotransplantation.

The authors thank Rob Holzknecht for preparation of the figures and Bekka Pecka and Kim Barber for assistance in preparing the manuscript. Work in the laboratories of the authors on which this communication was in part based is supported by the National Institutes of Health.

[1]  F. Bach,et al.  Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. , 1999, Journal of immunology.

[2]  F. Bach,et al.  Cellular basis of the proliferative response of human T cells to mouse xenoantigens , 1990, The Journal of experimental medicine.

[3]  J P Atkinson,et al.  Separation of self from non-self in the complement system. , 1987, Immunology today.

[4]  L. Matis,et al.  Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. , 1994, Transplantation.

[5]  W. Baldwin,et al.  Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. , 1993, Journal of immunology.

[6]  J. Platt,et al.  Complement-mediated regulation of tissue factor activity in endothelium , 1995, The Journal of experimental medicine.

[7]  D. Sachs,et al.  Inhibition of xenoreactive natural antibody production by retroviral gene therapy. , 1998, Science.

[8]  P. Casali,et al.  EVIDENCE THAT POLYREACTIVE ANTIBODIES ARE DEPOSITED IN REJECTED DISCORDANT XENOGRAFTS , 1993, Transplantation.

[9]  D. Candinas,et al.  Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment , 1997, Nature Medicine.

[10]  Y. Yuzawa,et al.  Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. , 1995, The American journal of pathology.

[11]  R. Pierson,et al.  Xenogeneic skin graft rejection is especially dependent on CD4+ T cells , 1989, The Journal of experimental medicine.

[12]  H. Auchincloss,et al.  EVIDENCE THAT MULTIPLE DEFECTS IN CELL‐SURFACE MOLECULE INTERACTIONS ACROSS SPECIES DIFFERENCES ARE RESPONSIBLE FOR DIMINISHED XENOGENEIC T CELL RESPONSES1 , 1992, Transplantation.

[13]  J. Platt,et al.  Transplantation of discordant xenografts: a challenge revisited. , 1996, Immunology today.

[14]  J. Atkinson,et al.  SEPARATION OF SELF FROM NON‐SELF IN THE COMPLEMENT SYSTEM: A ROLE FOR MEMBRANE COFACTOR PROTEIN AND DECAY ACCELERATING FACTOR , 1991, Clinical and experimental immunology.

[15]  H. Ohdan,et al.  Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism , 1998, The Journal of experimental medicine.

[16]  J. Platt,et al.  Transient perturbation of endothelial integrity induced by natural antibodies and complement , 1995, The Journal of experimental medicine.

[17]  J. Platt,et al.  Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. , 1996, Transplantation.

[18]  J. Platt,et al.  The fine cytokine line between graft acceptance and rejection , 2000, Nature Medicine.

[19]  F. Bach,et al.  Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction , 1976, The Journal of experimental medicine.

[20]  E. Reinherz,et al.  Invertebrate immune recognition, natural immunity and the evolution of positive selection. , 1994, Immunology today.

[21]  R. Michler,et al.  Target Cell Susceptibility to Lysis by Human Natural Killer Cells Is Augmented by α(1,3)-Galactosyltransferase and Reduced by α(1,2)-Fucosyltransferase* , 1999, The Journal of Biological Chemistry.

[22]  R. Bollinger,et al.  The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. , 1998, The Journal of clinical investigation.

[23]  J. Halperin,et al.  Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells , 1994, The Journal of experimental medicine.

[24]  M. Goddard,et al.  Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. , 2000, Transplantation.

[25]  J. Platt,et al.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury , 1995, Nature Medicine.

[26]  S. Sacks,et al.  Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. , 1996, The American journal of pathology.

[27]  J. Platt,et al.  Transplantation of discordant xenografts: a review of progress. , 1990, Immunology today.

[28]  H. Ohdan,et al.  Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. , 1999, The Journal of clinical investigation.

[29]  R. Lechler,et al.  Detection of primary direct and indirect human anti‐porcine T cell responses using a porcine dendritic cell population , 1996, European journal of immunology.

[30]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[31]  C. Janeway,et al.  Innate immunity: impact on the adaptive immune response. , 1997, Current opinion in immunology.

[32]  J. Platt,et al.  Platelet-endothelial cell interactions in a xenograft model. , 1997, Transplantation Proceedings.

[33]  F. Mangili,et al.  Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. , 1992, Journal of immunology.

[34]  A. Edge,et al.  Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation , 1997, Nature Medicine.

[35]  R. Colvin,et al.  Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. , 1998, Transplantation.

[36]  B. Hunt,et al.  Activation of human prothrombin by porcine aortic endothelial cells—a potential barrier to pig to human xenotransplantation , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[37]  L. Turka,et al.  Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes , 1998, Nature Medicine.

[38]  J. Platt,et al.  The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. , 2000, Transplantation.

[39]  J. Platt,et al.  PLATELET-MEDIATED ACTIVATION OF ENDOTHELIAL CELLS: IMPLICATIONS FOR THE PATHOGENESIS OF TRANSPLANT REJECTION1 , 2001, Transplantation.

[40]  T. Sablinski,et al.  Tolerance across discordant xenogeneic barriers , 1995 .

[41]  Lorri A. Lee,et al.  THE IMPORTANCE OF NONIMMUNE FACTORS IN RECONSTITUTION BY DISCORDANT XENOGENEIC HEMATOPOIETIC CELLS1,2 , 1994, Transplantation.

[42]  U. Galili.  Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. , 1993, Immunology today.

[43]  J. Platt,et al.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology. , 2001, The American journal of pathology.

[44]  T. Nagayasu,et al.  Expression of tissue factor mRNA in cardiac xenografts: clues to the pathogenesis of acute vascular rejection. , 2000, Transplantation.

[45]  J. Platt,et al.  Molecular barriers to xenotransplantation. , 1996, Transplantation.

[46]  R. Pardi,et al.  Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. , 1997, Transplantation.

[47]  J. Platt,et al.  Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. , 1995, Journal of immunology.

[48]  J. Pober,et al.  Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. , 1994, Immunity.

[49]  Yifan Dai,et al.  Cloned pigs produced by nuclear transfer from adult somatic cells , 2000, Nature.

[50]  W. Müller,et al.  Evolution of the innate and adaptive immune systems: relationships between potential immune molecules in the lowest metazoan phylum (Porifera) and those in vertebrates. , 1999, Transplantation.

[51]  J. Platt,et al.  Acute vascular rejection , 1998, Transplantation proceedings.

[52]  M. Yacoub,et al.  Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation. , 1997, The American journal of pathology.

[53]  P. Malý,et al.  Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse (*) , 1995, The Journal of Biological Chemistry.

[54]  M. Smyth,et al.  Accessory function for NK1.1+ natural killer cells producing interferon-gamma in xenospecific cytotoxic T lymphocyte differentiation. , 1999, Transplantation.

[55]  Amyj . Williams,et al.  NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation , 1994, The Journal of experimental medicine.

[56]  J. Platt,et al.  New directions for organ transplantation. , 1998, Nature.

[57]  David R. Sibley,et al.  Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model , 1985, Nature.

[58]  S. Shohet,et al.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. , 1988, The Journal of biological chemistry.

[59]  D. Cooper,et al.  Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. , 1992, Transplantation proceedings.

[60]  M. Sandrin,et al.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Ferran,et al.  Delayed xenograft rejection. , 1996, World journal of surgery.

[62]  J. Platt,et al.  Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha. , 2000, Circulation.

[63]  A. Dalmasso,et al.  Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. , 1998, Transplantation.

[64]  M. Waer,et al.  Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. , 1998, Journal of immunology.